Large-scale pharmacogenomics based drug discovery for ITGB3 dependent chemoresistance in mesenchymal lung cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Large-scale pharmacogenomics based drug discovery for ITGB3 dependent chemoresistance in mesenchymal lung cancer ; volume:17 ; number:1 ; day:18 ; month:12 ; year:2018 ; pages:1-7 ; date:12.2018
Molecular cancer ; 17, Heft 1 (18.12.2018), 1-7, 12.2018
- Creator
-
Hong, Soon-Ki
Lee, Haeseung
Kwon, Ok-Seon
Song, Na-Young
Lee, Hyo-Ju
Kang, Seungmin
Kim, Jeong-Hwan
Kim, Mirang
Kim, Wankyu
Cha, Hyuk-Jin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-018-0924-8
- URN
-
urn:nbn:de:101:1-2019020622331287106771
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hong, Soon-Ki
- Lee, Haeseung
- Kwon, Ok-Seon
- Song, Na-Young
- Lee, Hyo-Ju
- Kang, Seungmin
- Kim, Jeong-Hwan
- Kim, Mirang
- Kim, Wankyu
- Cha, Hyuk-Jin
- SpringerLink (Online service)
Other Objects (12)
Anticancer Drug Discovery: Role of Pharmacogenomics
Pharmacogenomics
6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
The pharmacogenomics journal
Pharmacogenomics and toxicogenomics
Pharmacogenomics and toxicogenomics
Clinical use of pharmacogenomics
Pharmacogenomics of neuropathic pain
Pharmacogenomics and migraine: possible implications
Pharmacogenetics, pharmacogenomics and airway disease
Current challenges and opportunities for pharmacogenomics: perspective of the Industry Pharmacogenomics Working Group (I-PWG)
Adipose stromal cell targeting suppresses prostate cancer epithelial-mesenchymal transition and chemoresistance
Anticancer Drug Discovery: Role of Pharmacogenomics
Pharmacogenomics
6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
The pharmacogenomics journal
Pharmacogenomics and toxicogenomics
Pharmacogenomics and toxicogenomics
Clinical use of pharmacogenomics
Pharmacogenomics of neuropathic pain
Pharmacogenomics and migraine: possible implications
Pharmacogenetics, pharmacogenomics and airway disease
Current challenges and opportunities for pharmacogenomics: perspective of the Industry Pharmacogenomics Working Group (I-PWG)
Adipose stromal cell targeting suppresses prostate cancer epithelial-mesenchymal transition and chemoresistance
Anticancer Drug Discovery: Role of Pharmacogenomics
Pharmacogenomics
6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
The pharmacogenomics journal
Pharmacogenomics and toxicogenomics
Pharmacogenomics and toxicogenomics
Clinical use of pharmacogenomics
Pharmacogenomics of neuropathic pain
Pharmacogenomics and migraine: possible implications
Pharmacogenetics, pharmacogenomics and airway disease
Current challenges and opportunities for pharmacogenomics: perspective of the Industry Pharmacogenomics Working Group (I-PWG)